BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price fell 2.4% during trading on Monday . The company traded as low as $1.98 and last traded at $2.02. 1,573,945 shares changed hands during mid-day trading, an increase of 84,566% from the average session volume of 1,859 shares. The stock had previously closed at $2.07.
BriaCell Therapeutics Stock Down 2.4%
The business has a 50 day simple moving average of $3.18 and a 200 day simple moving average of $3.22. The company has a market capitalization of $1.56 million, a PE ratio of 0.00 and a beta of 1.09.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Where Do I Find 52-Week Highs and Lows?
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- EV Stocks and How to Profit from Them
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Best Stocks Under $10.00
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
